Health Sciences Corporation (IWKS) today announced plans to pursue a reverse merger once a suitable partner is identified. The company hopes to leverage its broad leadership experience and track-record of value-creation to attract a profitable merger partner, creating a platform for future organic and acquisition-related expansion. The Company, a leading global supplier of medical, dental and veterinary products and trading publicly since 1983, now operates as a public shell.
With broad healthcare and medical experience, including Pharmacy Management, Contract Rehabilitation, Specialty Pharmacy, Pharmacoeconomics, Infection Control, Diagnostic Laboratory, Medical Devices, Medical, Dental and Veterinary Imaging and Drug Development, the Company is considering a variety of potential healthcare and medical platforms.
Prospective partner benefits could potentially include; flexible liquidity, favorable enterprise valuation, access to public capital for growth and M&A and favorable carry-forward tax offsets
Source: Biospace
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.